An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors

Overview of attention for article published in Annals of Oncology, March 2003

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

patent: 8 patents

guideline: 1 clinical guideline source

Readers on

mendeley: 65 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

Methods for treating pancreatic cancer using combination therapies

Grant US-12364691-B2

United States of America

22 Jul 2025

Combination therapy for cancer treatment

Grant US-11844795-B2

United States of America

19 Dec 2023

Methods for treating pancreatic cancer using combination therapies

Grant US-11369597-B2

United States of America

28 Jun 2022

Methods for treating metastatic pancreatic cancer using combination therapies comprising…

Grant US-11344552-B2

United States of America

31 May 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.